Vol. 85, Issue 5, 1635-1642, November 1998
Effect of cardiogenic and noncardiogenic pulmonary edema on
histamine responsiveness in sheep
James R.
Snapper1,
Peter L.
Lefferts1,
Weixuan
Lu2,
Young Sil
Hwang3, and
Jonathan D.
Plitman1
1 Department of Medicine,
Vanderbilt University School of Medicine, Nashville, Tennessee
37232-2650; 2 Peking Union Medical
College Hospital, Chinese Academy of Medical Sciences, Beijing
100730, China; and
3 Gyeongsang University College of
Medicine, Chinju 660-280, Korea
 |
ABSTRACT |
We compared the effects of cardiogenic pulmonary
edema, brief pulmonary vascular congestion without frank edema, and
noncardiogenic pulmonary edema on responsiveness to inhaled histamine
in chronically instrumented awake sheep. Histamine responsiveness was
measured before and after 1)
cardiogenic pulmonary edema induced by raising left atrial pressure to
35 cmH2O
(
Pla) for 3.5 h by partial obstruction of flow
across the mitral valve, 2) brief
cardiogenic congestion via
Pla for 0.5 h,
3) noncardiogenic pulmonary edema
induced by 25 mg/kg intravenous perilla ketone (PK), and
4) 3.5 h of monitoring without
Pla or PK (controls). Treatment for 3.5 h with
Pla
(n = 9) and PK
(n = 11) each significantly lessened
the histamine dose required to cause a fall to 65% of baseline dynamic
lung compliance (ED65Cdyn), i.e.,
increased responsiveness. Sheep treated for 0.5 h with
Pla
(n = 7) and controls
(n = 5) showed no significant change
in ED65Cdyn. Intravenous atropine
(0.1 mg/kg) before the second histamine challenge altered neither the
reduction of ED65Cdyn in
Pla (n = 8) and PK
(n = 9) sheep nor the
ED65Cdyn level of controls
(n = 9). These data imply that the
local effects of edema, rather than bronchial vascular hemodynamics,
cholinergic reflexes, and permeability changes, are germane to lung
hyperresponsiveness during pulmonary edema in sheep.
bronchi; bronchial hyperreactivity; lung
 |
INTRODUCTION |
HYPERRESPONSIVENESS to nonantigenic bronchial
provocation occurs in humans during pulmonary vascular congestion and
cardiogenic pulmonary edema (3, 14, 18-20). Hyperresponsiveness is
also seen in animals during noncardiogenic pulmonary edema (8). Although it has not been documented per se in humans with the adult
respiratory distress syndrome, such patients do have
increased airway resistance which can be reduced by bronchodilators
(27), and increased airway responsiveness has been demonstrated in some survivors of adult respiratory distress syndrome (10, 22). Because lung
hyperresponsiveness may contribute to the symptoms (e.g., cardiac
asthma) and abnormal lung mechanics characteristic of pulmonary edema,
an understanding of the mechanisms underlying pulmonary edema-induced
lung hyperresponsiveness is potentially important.
The present experiments compare the lung responsiveness of chronically
instrumented awake sheep to histamine inhaled during cardiogenic
pulmonary edema, brief pulmonary vascular congestion, and
noncardiogenic pulmonary edema. Cardiogenic pulmonary edema and brief
pulmonary vascular congestion both share increased hydrostatic pressure
and vascular congestion, whereas altered hydrostatic pressure and
vascular congestion are not observed in noncardiogenic pulmonary edema.
Pulmonary edema formation is observed in both cardiogenic and
noncardiogenic pulmonary edema but is not significant during brief
periods of vascular congestion. Noncardiogenic pulmonary edema is
associated with increased pulmonary microvascular permeability, the
influx of inflammatory cells into the lungs, and the release of a
variety of mediators which potentially could mediate alterations in
lung responsiveness. Similar changes are not observed in cardiogenic pulmonary edema or during brief periods of vascular congestion. These
comparisons thus potentially allow us to discern the relative import of
specific mechanisms in pulmonary edema-related increased lung
hyperresponsiveness (15). Some of these mechanisms may also be relevant
to asthma. Because cholinergic mechanisms have been proposed as
contributing to altered airway responsiveness in a dog pulmonary
congestion model (9), we also studied the effects of atropine on
alterations in lung responsiveness in our ovine models of cardiogenic
and noncardiogenic pulmonary edema.
 |
METHODS |
Sheep preparation.
Yearling sheep of either sex weighing 30-40 kg were instrumented
for measurement of vascular pressures and lung mechanics as previously
described (8, 25). After anesthesia was induced with intravenous
thiamylal and general endotracheal anesthesia was induced with
halothane, catheters were placed directly into the left atrium and
pulmonary artery through a left thoracotomy so pressure measurements
could be made. An additional balloon-tipped catheter (18-Fr Foley) was
positioned in the mitral valve orifice through the left atrial wall.
Inflation of the balloon produced partial mitral valve obstruction and
increased left atrial pressure (
Pla). An envelope made from
0.01-in. thick silicone sheeting (Specialty Manufacturing, Saginaw,
MI), measuring 4 × 3 cm, with Silastic catheters (0.157-in. ID)
extending from within the envelope, was positioned within the pleural
space for measurement of intrapleural pressure (Ppl). Through an
incision on the neck, catheters were placed into the aorta via the
carotid artery and into the superior vena cava via the external jugular
vein. A tracheostomy was performed, and a no. 10 cuffed tracheostomy
tube (Shiley, Irvine, CA) was inserted. The sheep were allowed 5-7
days to recover from the operation. Free access to food and water was
allowed during this period. All surgery and experimentation was
performed in compliance with US Department of Agriculture animal care
regulations and under the supervision of the veterinarians of the
Vanderbilt University Division of Animal Care.
Physiological measurements.
Awake sheep were studied while they were standing in a specially
constructed, pressure-compensated, integrated-flow, whole body
plethysmograph connected to an external valve via flexible noncollapsible tubing (8). A constant bias flow of humidified air was
used to reduce the effective dead space of the tubing. Tidal volume
(VT) was measured
by pressure compensating the integrated signal from the
plethysmographic pressure transducer, with flow (
)
determined by electronically differentiating the volume
signal. Airway opening pressure (Pao) was measured in the
trachea by a multiple-side hole catheter positioned 2 cm beyond the
distal end of the tracheostomy tube. Ppl was obtained from the pleural envelope, and transpulmonary pressure (Ptp) was measured as the pressure difference between Ppl and Pao. The pressures from the plethysmograph, catheters, and Silastic pleural envelope were measured
by using similar differential transducers (model MP-45; Validyne
Engineering, Northridge, CA), and the pressure signals were tuned to 20 Hz to eliminate phasic distortion.
Before each set of lung mechanics measurements was made, the sheep's
lungs were inflated to 40 cmH2O
Pao by using the bias flow and occluding the expiratory limb of the
tubing. Simultaneous VT/
and
VT/Ptp curves were recorded
during spontaneous respiration on a dual-beam storage oscilloscope
(Tektronix, Wilsonville, OR) and photographed for calculation of
dynamic lung compliance (Cdyn) and resistance to airflow across the
lungs (RL). Cdyn was
calculated as VT divided by Ptp
at points of zero flow and expressed in liters per centimeters
H2O at
BTPS.
RL was calculated by dividing
Ptp by flow at mid-VT and
expressed as centimeters H2O per
liter per second at BTPS. The external
valve was obstructed at end expiration to allow calculation of thoracic
gas volume (TGV) at functional residual capacity by the modified
Boyle's law technique.
Lung responsiveness to aerosol histamine was determined using solutions
of histamine diphosphate (Sigma Chemical, St. Louis, MO) in 0.9%
saline. Concentrations are expressed as milligrams of histamine base
per milliliter. Aerosols were generated by a Collison nebulizer (BGI,
Waltham, MA) driven by 100%
O2-producing output particles of
2- to 4-µm median diameter. Aerosols (0.0, 0.003, 0.01, 0.03, 0.1, 0.3, 1.0, 3.0, 10.0, and 30.0 mg/ml histamine) were administered by
inflating the lungs with the output of the nebulizer five times to a
Pao of 40 cmH2O.
VT/
and
VT/Ptp curves were continuously
monitored, and Cdyn, RL, and TGV
were calculated at the time of maximal change (~1 min after the last
inflation). The concentration of histamine was increased in stepwise
fashion until Cdyn decreased to <65% of its baseline value, a level
of response that all sheep included in this study reached at a
histamine concentration of
30.0 mg/ml. The effective dose of
histamine that would have caused a reduction of Cdyn to 65% of its
baseline value (ED65Cdyn) was
calculated by interpolation, assuming a linear dose-response
relationship between the last two histamine doses. If
RL doubled or TGV increased by
25%, the respective effective doses
(ED200RL
and ED125TGV) were also calculated.
Pulmonary artery pressure, Pla, and aortic blood pressure were
continuously measured by using saline-filled pressure transducers (model 1208C, Hewlett-Packard, Andover, MA).
Preparation of 3-furyl ketones (perilla ketone).
1-(3-Furyl)-4-methyl-1-pentanone (perilla ketone or PK) is
a toxic product of the purple mint plant Perilla
frutescens. It causes increased pulmonary microvascular
permeability and pulmonary edema without acute changes in pulmonary
hemodynamics (4). It was prepared from 3-furoic acid (Sigma Chemical)
by the method of Garst and Wilson (7). PK (1 g/ml) was then mixed 1:1
(vol/vol) with dimethyl sulfoxide (Sigma Chemical).
Experimental protocols.
Pla of 35 cmH2O and 25 mg/kg of intravenous PK were used as models of cardiogenic and
noncardiogenic pulmonary edema, respectively. We have observed that
these regimens cause similar linear increases in fluid transit across
the lung (measured as lung lymph flow) and in lung edema shown on chest
radiograph over a 4-h monitoring period (2). Eleven sheep were studied
for the effects of PK. After 1 h of stable baseline measurements,
histamine responsiveness (initial value) was determined. PK was then
infused intravenously over 20 min. The animals were monitored for 3.5 h
after the initiation of PK infusion, at which point histamine
responsiveness was determined again (final value). Because PK causes
progressive, irreversible respiratory failure, the sheep that received
PK were killed with an intravenous overdose of barbiturate at the end
of the protocol. Sixteen sheep were studied in the
Pla
experiments. After 1 h of stable baseline measurements, initial
histamine responsiveness was determined. The left atrial balloon was
then gradually inflated over 10-15 min so as to cause Pla to
increase to 35 cmH2O. This pressure was maintained, and animals were monitored for either 0.5 h
(n = 7) or 3.5 h
(n = 9), at which point final
histamine responsiveness was determined. At the end of the
Pla
experiments, the mitral valve balloon was deflated, allowing the Pla to
return to normal. To assess the reproducibility of the response to
elevated Pla, two 3.5-h
Pla experiments were performed 3 wk
apart on an individual sheep. Similarly, two 0.5-h
Pla studies
were performed on another individual sheep.
Five of the surgically prepared sheep served as controls, receiving two
determinations of inhaled histamine responsiveness separated by 3.5 h,
but they received neither PK nor
Pla. Twenty-six additional
sheep were studied in control, PK, or 3.5-h
Pla protocols with
the addition of the intravenous infusion of 0.1 mg/kg of atropine 30 min before the final determination of histamine responsiveness (n = 8 for 3.5-h
Pla,
n = 9 for PK,
n = 9 for controls receiving neither
Pla nor PK). We have previously documented that this dose of
atropine causes dilated pupils that are unreactive to light in the
awake sheep and abolishes the effect of electrical stimulation of the
vagus (5 V, 20 Hz, 20 s) on lung mechanics in the anesthetized sheep
(15).
If an animal showed distress or significant respiratory failure during
an experiment, the experiment was terminated and the sheep was either
killed with intravenous barbiturate (PK trial) or the left atrial
balloon was deflated (
Pla trial).
Statistics.
Data were analyzed by a combination of parametric and distribution-free
statistics (Statistica/W, StatSoft, Tulsa, OK; and SigmaStat, Jandel
Scientific, San Rafael, CA). After analysis of variance, multiple
comparisons were performed by Newman-Keuls test, by Dunn's test, or by
serial Wilcoxon or Mann-Whitney tests, with Bonferroni correction of
the resultant P values. The Bonferroni correction was also applied to the instances of repetitive
distribution-free correlation analysis. The null hypothesis was
rejected for either at P < 0.05.
 |
RESULTS |
Primary studies.
The pattern of changes in lung mechanics induced by aerosol histamine,
in both the absence and the presence of pulmonary edema, was similar to
those previously reported in sheep (24). Because approximately
two-thirds of the sheep studied failed to double RL, even with the highest
concentrations of histamine, and >90% of sheep failed to increase
TGV by 25%, alterations in lung responsiveness are presented in terms
of Cdyn. Figure 1 contains the
ED65Cdyn data from the individual
control sheep before and after a 3.5-h monitoring period. There was no
significant change in ED65Cdyn over this period. Figure 1 also shows
ED65Cdyn values for individual sheep before and after either PK, 3.5 h of
Pla, or 0.5 h of
Pla. ED65Cdyn was
significantly reduced after PK and after 3.5 h of
Pla, but 0.5 h of
Pla caused no significant change. The magnitude of
increase in histamine responsiveness of the individual animals (measured as log10 of final
ED65Cdyn
log10 of initial
ED65Cdyn) did not differ
significantly between the PK and 3.5-h
Pla groups. The PK and
3.5-h
Pla animals characteristically showed signs that were
consistent with pulmonary edema (tachypnea, frothy liquid coughed from
tracheostomy tube) that increased over the duration of the monitoring
period. The control and 0.5-h
Pla animals did not. The ED65Cdyn data for the
four groups are summarized numerically in Table
1. There were no significant differences
among the groups at baseline.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Responsiveness to inhaled histamine of control sheep
(n = 5) before and after a 3.5-h
interval, before and after 3.5 h of perilla ketone (PK;
n = 11), before and after 3.5 h of
increased left atrial pressure ( Pla;
n = 9), and before and after 0.5 h of
Pla (n = 7). Each pair of
connected data symbols represents a single animal. Ordinate displays
histamine concentrations on a
log10 scale. A decrease in
effective dose to reduce dynamic compliance to 65% of baseline value
(ED65Cdyn) implies increased
responsiveness. NS, not significant.
|
|
Figure 2 shows the results of
within-subject repetition of the 3.5-h and 0.5-h
Pla protocols.
The first study on each animal (solid symbols) is part of the data
displayed in Fig. 1 and summarized in Table 1. The responses in the
repeat studies (open symbols) are similar in magnitude and direction to
those in the first studies.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Within-subject repetition of the 3.5-h Pla (solid symbols) and
0.5-h Pla protocols (open symbols);
n = 1 for each. Ordinate displays
histamine concentrations on a
log10 scale; a reduced
ED65Cdyn value implies increased
responsiveness.
|
|
Figures
3-6
contain the complete initial and final histamine dose-response curves
for the individual sheep in the four experimental groups. These data
are shown primarily for comparison of the baseline Cdyn values
[abscissa = S (saline inhalation)] at the beginning of the
initial and final dose-response curves. Note that, in those groups
shown to have significantly reduced final
ED65Cdyn (i.e., PK and 3.5-h
Pla), there appears to be considerable downward shift in Cdyn
at baseline. The magnitude of the shift in Cdyn of the individual
animals (measured as percent change from baseline) did not differ
significantly between the PK and 3.5-h
Pla groups. Table
2 summarizes the Cdyn data for the four
groups immediately before the initial and final inhaled-histamine
challenges. There were no significant differences among the initial
baselines. The PK and 3.5-h
Pla groups had significantly
reduced baseline Cdyn values before the final histamine challenge,
whereas the control and 0.5-h
Pla groups did not.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Inhaled histamine dose-response curves of control sheep
(n = 5) before (open symbols) and
after (solid symbols) a 3.5-h interval. Each pair of identically
numbered curves represents a single animal. Cdyn, dynamic compliance.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 4.
Inhaled histamine dose-response curves of sheep
(n = 11) before (open symbols) and 3.5 h after (solid symbols) infusion of PK. Each pair of identically
numbered curves represents a single animal.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
Inhaled histamine dose-response curves of sheep
(n = 9) before (open symbols) and
after (solid symbols) 3.5 h of Pla. Each pair of identically
numbered curves represents a single animal.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6.
Inhaled histamine dose-response curves of sheep
(n = 7) before (open symbols) and
after (solid symbols) 0.5 h of Pla. Each pair of identically
numbered curves represents a single animal.
|
|
Figure 7 contains the baseline Cdyn values
measured before the initial and final histamine challenges in each of
the four experimental groups. Each datum is plotted vs. its associated ED65Cdyn value to allow
investigation of the possibility of a correlation between a value of
Cdyn and the ED65Cdyn measured immediately thereafter. Table 3 contains
the various correlation coefficients obtained. The
n values in this table reflect not the
number of animals but the number of pairs of individual Cdyn and
ED65Cdyn values used in the
correlation calculation. The division of the data into Control+0.5-h
Pla and PK+3.5-h
Pla separates those groups which did
not have a significant reduction of Cdyn and
ED65Cdyn over the course of the
experiments from those which did. Significant correlations occur only
when groups with and without significant reduction of these values are
analyzed simultaneously.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 7.
Cdyn vs. ED65Cdyn
(log10 scale) by experimental
group and sequence. See Table 3 for corresponding correlation
coefficients.
|
|
Atropine studies.
Figure 8 shows the histamine responsiveness
data from the three groups of animals given intravenous atropine before
the final histamine challenge. In the presence of atropine, the PK and
3.5-h
Pla sheep showed a significant decrease in
ED65Cdyn at the end of the
monitoring period. The magnitude of the increase in responsiveness of
the individual animals (measured as
log10 of final
ED65Cdyn
log10 of initial
ED65Cdyn) did not significantly
differ between the PK and PK+atropine groups nor between the 3.5-h
Pla and 3.5-h
Pla+atropine groups. Atropine also failed
to alter the histamine responsiveness of the control animals.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 8.
Responsiveness to inhaled histamine of sheep before and after exposure
to PK (n = 9), 3.5 h of Pla
(n = 8), and a 3.5-h control
monitoring period (n = 9). Intravenous
atropine (0.1 mg/kg) was given 0.5 h before the second histamine
challenge. Each pair of connected data symbols represents a single
animal. Ordinate displays histamine concentrations on a
log10 scale. A reduced
ED65Cdyn implies increased
responsiveness.
|
|
 |
DISCUSSION |
Lung edema may alter lung responsiveness through a variety of
mechanisms. Several reflect local effects of edema fluid. These are
potentially pertinent irrespective of whether the edema is due to
increased permeability or to increased hydrostatic pressure, in that
the pattern of accumulation of both types of edema appears to be
similar (26).
Edema can stimulate vagal afferents (13). Both rapidly adapting
receptors and unmyelinated C fibers (Paintal's "J receptors") are activated in this way (16, 17). Cholinergic efferent tone could
then reflexly increase, and airway hyperresponsiveness could result
from enhanced bronchomotor activity, increased secretion of
intraluminal liquid, and also from bronchial vasodilation (see below).
Antidromic stimulation of sensory nerve fibers in the lung might also
result, causing the local release by axon reflex of proinflammatory
neuropeptides such as substance P and neurokinin A. These could have
responsiveness-enhancing effects including increased vascular
permeability, which could accelerate edema formation, alteration of
airway smooth muscle tone, and vasodilation.
Other potential mechanisms of hyperresponsiveness relate primarily to
states of increased permeability or of increased hydrostatic pressure.
Bronchial hemodynamic abnormalities, for example, pertain principally
to cardiogenic pulmonary edema. The circulation to the intrapulmonary
airways of the sheep drains via the pulmonary vessels. Thus increased
Pla may congest and distend the bronchial vasculature. Pla is not
affected by PK. It has been shown, in an exsanguinated perfused model,
that hydrostatic overload of the bronchial circulation does distend the
submucosal bronchial plexus of sheep intrapulmonary airways (11).
Increased lung permeability, a hallmark of noncardiogenic pulmonary
edema, could facilitate the access of agonists to their sites of
action, thus increasing lung responsiveness. Increased permeability can
also occur during cardiogenic edema; disruption of the blood-gas
barrier has been observed in rabbit lungs after acute hydrostatic
overload of the pulmonary vasculature (1). The increase in lung
permeability in sheep acutely exposed to
Pla of 35 cmH2O is modest, particularly
compared with that observed after PK (2). Pulmonary microvascular
permeability seems to be decreased, possibly adaptively, in humans with
mitral stenosis or chronic left heart failure (6).
In the present studies, both PK (a model of noncardiogenic pulmonary
edema) and 3.5-h
Pla (a model of cardiogenic pulmonary edema)
similarly and significantly increase lung responsiveness to inhaled
histamine. This finding is unaffected by intravenous atropine, and it
does not occur when the exposure to
Pla is limited to 0.5 h.
Based on the classification of mechanisms outlined above, what can be inferred?
First, the lack of hyperresponsiveness in the 0.5-h
Pla model
tends to deny the importance of bronchial hemodynamics in the genesis
of hyperresponsiveness in the sheep while emphasizing the importance of
the effects of edema fluid. When Pla is abruptly raised, the effect on
the bronchial circulation is quite rapid
a significant fall in
bronchial blood flow can be measured within a few minutes after
elevation of Pla in sheep. On the other hand, we have radiographically
observed minimal or no accumulation of lung edema after only 1 h of
Pla of 30 cmH2O
in sheep (2). Thus our 0.5-h
Pla model would appear to
represent cardiogenic bronchial hemodynamic changes in the near absence
of lung edema. The principal factor shared by the 3.5-h
Pla and
PK models is the presence of edema.
Second, the lack of effect of atropine in the present experiments
implies that the cholinergic vagal reflex effects described above are
relatively unimportant in this situation in the sheep, analogous to our
previous findings on the lung hyperresponsiveness observed in the ovine
endotoxemia model of acute lung injury (8). This inference can probably
be extended to some degree to include the local release of
neuropeptides, the effects of which seem to be partially mediated by
acetylcholine release in some species, including sheep (5). Our
findings seem at odds with those of Kikuchi et al. (9), who observed
vagally mediated synergy between the effects of inhaled histamine and
brief periods of pulmonary congestion on lung mechanics in dogs. Their
study was designed differently from ours, however. In addition to the
difference in species used and the use of vagotomy rather than
muscarinic blockade, their experiments consisted of increasing doses of
inhaled histamine (with or without prior vagotomy) followed by 1-min
periods of
Pla. Thus their protocol seems to test
responsiveness to
Pla after altering lung mechanics with
histamine rather than responsiveness to histamine after periods of
Pla.
These inferences emphasize the potential importance of the local
mechanical effects of edema liquid in the genesis of pulmonary edema-related lung hyperresponsiveness. The present experiments do not
directly address the potential involvement of permeability, but this
mechanism would not seem to be intimately involved because 3.5-h
Pla and PK cause similar degrees of hyperresponsiveness. Furthermore, studies in persons with asthma and in smokers have not
suggested a strong relationship between epithelial permeability (measured as 99Tc-diethylene
triamine pentaacetate clearance) and airway responsiveness (12).
Alterations in lung responsiveness were calculated from
histamine-induced changes in Cdyn. Histamine causes changes in the peripheral lungs [2-mm airways and smaller (23)] and does
not, in sheep, consistently cause changes in
RL or TGV (24). In our models,
neither cardiogenic nor noncardiogenic pulmonary edema facilitated
histamine-induced changes in RL
or TGV. Frequency dependence of compliance was not noted in these
spontaneously breathing sheep, in which the respiratory rate varied
from ~4 breaths/min to <1 breaths/s. In the presence
of pulmonary edema, factors such as inhomogeneity of airflow, airway
closure, and changes in tissue resistance may contribute to the
observed alteration in histamine responsiveness.
It is important to recognize that those groups of sheep with
significant reductions in ED65Cdyn
also had significant reductions of Cdyn at the time of the final
histamine challenge. This is a potentially confounding influence in the
interpretation of the data, in that the conditions of the experiment
alter lung mechanics in a way not explicit in the normalized principal
outcome variable, ED65Cdyn. It
could be claimed, furthermore, that the reduction of
ED65Cdyn merely reflects the
reduction in Cdyn, which could result from reduced lung volume, reduced
airway caliber, and/or altered aerosol deposition. If this were
true, one would expect there to be a significant correlation between
Cdyn and ED65Cdyn. In the ovine
endotoxemia model of acute lung injury, we have observed no correlation
between reductions in ED65Cdyn and
reductions in either Cdyn or functional residual capacity (8), although
in the present study (Table 3), significant correlations between Cdyn
and ED65Cdyn are found. We feel
that these correlations are potentially misleading in that they occur
only with the simultaneous analysis of data that include clusters of
animals both with and without altered Cdyn and
ED65Cdyn. In other words, the
"significant" correlations may well be artifacts of
superimposition of heterogeneous groups, which places one "cloud"
of points in the right upper quadrant of the graph (Fig. 7)
and another cloud in the lower left, and a line is then drawn between
the two. If one looks for significant correlations within a single
cloud [e.g., all control and 0.5-h
Pla animals (no
pulmonary edema) or the final values of all PK and 3.5-h
Pla
animals (pulmonary edema)], there are none. We cannot exclude the
possibility that more meaningful correlations might emerge with larger
groups. We would argue that even if
ED65Cdyn were in some instances an
indirect reflection of Cdyn, the animals with significantly reduced
ED65Cdyn would still, by
definition, be hyperresponsive to bronchial provocation.
One's ability to draw parallels between this hyperresponsive state and
the hyperresponsive state of human pulmonary edema [in which, as
in the sheep, lung compliance is reduced (21)] is not impaired by
the potential involvement of Cdyn.
In summary, we have shown that responsiveness to bronchial provocation
with inhaled histamine in sheep is increased during cardiogenic and
noncardiogenic pulmonary edema and that this increase is not
antagonized by intravenous atropine. Brief pulmonary-bronchial vascular
congestion does not cause hyperresponsiveness to histamine. From these
findings, we infer that the local structural effects of edema fluid,
rather than bronchial hemodynamics or vagal reflexes, are the principal
factors in the genesis of the hyperresponsiveness.
 |
ACKNOWLEDGEMENTS |
This work was supported by National Heart, Lung, and Blood
Institute Grants HL-27274, HL-46971, and HL-07123.
 |
FOOTNOTES |
Address for reprint requests: J. R. Snapper, Glaxo Wellcome, #17.2213
Five Moore Dr., Research Triangle Park, NC 27709.
Received 24 April 1997; accepted in final form 22 June 1998.
 |
REFERENCES |
1.
Bachofen, H.,
S. Schürch,
and
E. R. Weibel.
Experimental hydrostatic pulmonary edema in rabbit lungs. Barrier lesions.
Am. Rev. Respir. Dis.
147:
997-1004,
1993[Medline].
2.
Bernard, G. R.,
N. A. Pou,
J. W. Coggeshall,
F. E. Carroll,
and
J. R. Snapper.
Comparison of pulmonary dysfunction caused by cardiogenic and noncardiogenic pulmonary edema.
Chest
108:
798-803,
1995[Abstract/Free Full Text].
3.
Cabanes, L. R.,
S. N. Weber,
R. Matran,
J. Regnard,
M. O. Richard,
M. E. Degeorges,
and
A. Lockhart.
Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function.
N. Engl. J. Med.
320:
1317-1322,
1989[Abstract].
4.
Coggeshall, J. W.,
P. L. Lefferts,
M. J. Butterfield,
G. R. Bernard,
F. E. Carroll,
N. A. Pou,
and
J. R. Snapper.
Perilla ketone. A model of increased pulmonary microvascular permeability pulmonary edema in sheep.
Am. Rev. Respir. Dis.
136:
1453-1458,
1987[Medline].
5.
Corcoran, B. M.,
and
A. L. Haigh.
The effect of tachykinins on sheep bronchomotor tone.
Exp. Physiol.
77:
471-479,
1992[Abstract].
6.
Davies, S. W.,
J. Bailey,
J. Keegan,
R. Balcon,
R. M. Rudd,
and
D. P. Lipkin.
Reduced pulmonary microvascular permeability in severe chronic left heart failure.
Am. Heart J.
124:
137-142,
1992[Medline].
7.
Garst, J. E.,
and
B. J. Wilson.
Synthesis and analysis of various 3-furyl ketones from Perilla frutescens.
J. Agric. Food Chem.
32:
1083-1087,
1984.
8.
Hutchison, A. A.,
J. M. Hinson, Jr.,
K. L. Brigham,
and
J. R. Snapper.
Effect of endotoxin on airway responsiveness to aerosol histamine in sheep.
J. Appl. Physiol.
54:
1463-1468,
1983[Abstract/Free Full Text].
9.
Kikuchi, R.,
K. Sekizawa,
H. Sasaki,
Y. Hirose,
N. Matsumoto,
T. Takishima,
and
J. Hildebrandt.
Effects of pulmonary congestion on airway reactivity to histamine aerosol in dogs.
J. Appl. Physiol.
57:
1640-1647,
1984[Abstract/Free Full Text].
10.
Lakshminararayan, S.,
and
L. D. Hudson.
Pulmonary function following the adult respiratory distress syndrome.
Chest
74:
489-490,
1978[Free Full Text].
11.
Mariassy, A. T.,
H. Gazeroglu,
and
A. Wanner.
Morphometry of the subepithelial circulation in sheep airways. Effect of vascular congestion.
Am. Rev. Respir. Dis.
143:
162-166,
1991[Medline].
12.
O'Byrne, P. M.,
M. Dolovich,
R. Dirks,
R. S. Roberts,
and
M. T. Newhouse.
Lung epithelial permeability: relation to nonspecific airway responsiveness.
J. Appl. Physiol.
57:
77-84,
1984[Abstract/Free Full Text].
13.
Paintal, A. S.
Mechanism of stimulation of type J pulmonary receptors.
J. Physiol. (Lond.)
203:
511-532,
1969[Abstract/Free Full Text].
14.
Pison, C.,
J. L. Malo,
J. L. Rouleau,
J. Chalaoui,
H. Ghezzo,
and
J. Malo.
Bronchial hyperresponsiveness to inhaled methacholine in subjects with chronic left heart failure at a time of exacerbation and after increasing diuretic therapy.
Chest
96:
230-235,
1989[Abstract/Free Full Text].
15.
Plitman, J. D.,
and
J. R. Snapper.
Nonspecific airway hyperresponsiveness: mechanisms and meaning.
In: Current Pulmonology, edited by D. H. Simmons,
and D. F. Tierney. Chicago: Mosby-Year Book, 1992, vol. 13, chapt. 6, p. 143-192.
16.
Ravi, K.,
and
C. T. Kappagoda.
Responses of pulmonary C-fibre and rapidly adapting receptor afferents to pulmonary congestion and edema in dogs.
Can. J. Physiol. Pharmacol.
70:
68-76,
1992[Medline].
17.
Roberts, A. M.,
J. Bhattacharya,
H. D. Schultz,
H. M. Coleridge,
and
J. C. Coleridge.
Stimulation of pulmonary vagal afferent C-fibers by lung edema in dogs.
Circ. Res.
58:
512-522,
1986[Abstract/Free Full Text].
18.
Rolla, G.,
C. Bucca,
E. Caria,
E. Scappaticci,
and
S. Baldi.
Bronchial responsiveness in patients with mitral valve disease.
Eur. Respir. J.
3:
127-131,
1990[Abstract].
19.
Rolla, G.,
E. Scappaticci,
S. Baldi,
and
C. Bucca.
Methacholine inhalation challenge after rapid saline infusion in healthy subjects.
Respiration
50:
18-22,
1986[Medline].
20.
Sasaki, F.,
T. Ishizaki,
J. Mifune,
M. Fujimura,
S. Nishioka,
and
S. Miyabo.
Bronchial hyperresponsiveness in patients with chronic congestive heart failure.
Chest
97:
534-538,
1990[Abstract/Free Full Text].
21.
Sharp, J. T.,
G. T. Griffith,
I. L. Bunnell,
and
D. G. Greene.
Ventilatory mechanics in pulmonary edema in man.
J. Clin. Invest.
37:
111-117,
1958.
22.
Simpson, D. L.,
M. Goodman,
S. L. Spector,
and
T. L. Petty.
Long-term follow-up and bronchial reactivity testing in survivors of the adult respiratory distress syndrome.
Am. Rev. Respir. Dis.
117:
449-454,
1978[Medline].
23.
Snapper, J. R.,
and
P. L. Lefferts.
Effects of aerosol histamine and carbachol on central and peripheral airflow resistance in sheep.
J. Appl. Physiol.
61:
760-765,
1986[Abstract/Free Full Text].
24.
Snapper, J. R.,
P. L. Lefferts,
A. A. Stecenko,
J. M. Hinson, Jr.,
and
E. L. Dyer.
Bronchial responsiveness to nonantigenic bronchoconstrictors in awake sheep.
J. Appl. Physiol.
61:
752-759,
1986[Abstract/Free Full Text].
25.
Snapper, J. R.,
J. H. Newman,
G. R. Bernard,
and
K. L. Brigham.
Effects of alveolar hypoxia during partial mitral valve obstruction in unanesthetized sheep.
Am. Rev. Respir. Dis.
131:
65-68,
1985[Medline].
26.
Staub, N. C.,
H. Nagano,
and
M. L. Pearce.
Pulmonary edema in dogs, especially the sequence of fluid accumulation in lungs.
J. Appl. Physiol.
22:
227-240,
1967[Free Full Text].
27.
Wright, P. E.,
L. C. Carmichael,
A. P. Wheeler,
and
G. R. Bernard.
Effects of bronchodilators on lung mechanics in the acute respiratory distress syndrome (ARDS).
Chest
106:
1517-1523,
1994[Abstract/Free Full Text].
J APPL PHYSIOL 85(5):1635-1642
8570-7587/98 $5.00
Copyright © 1998 the American Physiological Society